Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,881 | 514 | 99.6% |
| Education | $30.81 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,960 | 170 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $858.54 | 49 | $0 (2024) |
| Janssen Biotech, Inc. | $857.73 | 90 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $631.85 | 40 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $274.92 | 16 | $0 (2017) |
| IRONWOOD PHARMACEUTICALS, INC | $231.81 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $195.06 | 10 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $187.92 | 19 | $0 (2018) |
| PFIZER INC. | $175.21 | 13 | $0 (2024) |
| Ardelyx, Inc. | $172.40 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,688 | 91 | ABBVIE INC. ($649.53) |
| 2023 | $1,240 | 68 | ABBVIE INC. ($594.06) |
| 2022 | $785.41 | 45 | ABBVIE INC. ($616.59) |
| 2021 | $539.90 | 33 | AbbVie Inc. ($403.65) |
| 2020 | $271.38 | 16 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($67.02) |
| 2019 | $874.55 | 57 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($214.46) |
| 2018 | $1,356 | 105 | AbbVie, Inc. ($316.60) |
| 2017 | $1,157 | 101 | Valeant Pharmaceuticals North America LLC ($274.92) |
All Payment Transactions
516 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.11 | General |
| Category: GI | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, PLENVU | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.74 | General |
| Category: GI | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Immunology | ||||||
| 10/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: VIROLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Rare Disease | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Immunology | ||||||
| 09/13/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 734 | 7,670 | $619,190 | $198,023 |
| 2022 | 16 | 622 | 4,551 | $426,901 | $131,830 |
| 2021 | 16 | 690 | 740 | $352,657 | $77,537 |
| 2020 | 13 | 615 | 655 | $304,932 | $64,581 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 16 | 6,900 | $254,460 | $119,413 | 46.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 132 | 132 | $131,983 | $26,899 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 120 | $25,461 | $10,981 | 43.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 107 | 108 | $63,959 | $8,299 | 13.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 102 | $14,757 | $5,937 | 40.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 32 | 32 | $23,263 | $5,679 | 24.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 71 | 71 | $24,822 | $4,544 | 18.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $13,907 | $3,121 | 22.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 32 | 32 | $26,301 | $2,982 | 11.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $7,476 | $2,878 | 38.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $9,267 | $2,030 | 21.9% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 27 | 27 | $7,863 | $1,362 | 17.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 19 | $4,349 | $1,207 | 27.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 16 | 23 | $2,356 | $1,173 | 49.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,203 | $916.10 | 28.6% |
| 43450 | Dilation of esophagus | Facility | 2023 | 20 | 20 | $5,763 | $600.90 | 10.4% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 11 | 3,900 | $130,299 | $67,847 | 52.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 100 | 100 | $100,491 | $19,487 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 123 | $15,392 | $7,961 | 51.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 88 | 90 | $55,564 | $6,774 | 12.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 71 | $13,365 | $6,730 | 50.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 67 | 67 | $20,159 | $5,147 | 25.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 42 | 42 | $37,798 | $4,199 | 11.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $8,051 | $3,369 | 41.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 16 | 16 | $12,073 | $2,965 | 24.6% |
About Christine Herdman
Christine Herdman is a Gastroenterology healthcare provider based in Newark, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1487783767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christine Herdman has received a total of $7,911 in payments from pharmaceutical and medical device companies, with $1,688 received in 2024. These payments were reported across 516 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($7,881).
As a Medicare-enrolled provider, Herdman has provided services to 2,661 Medicare beneficiaries, totaling 13,616 services with total Medicare billing of $471,971. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Newark, DE
- Active Since 03/05/2007
- Last Updated 07/26/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1487783767
Products in Payments
- XIFAXAN (Drug) $739.24
- MAVYRET (Drug) $694.31
- STELARA (Biological) $533.68
- SKYRIZI (Biological) $487.80
- RINVOQ (Biological) $454.49
- HUMIRA (Biological) $316.71
- DUPIXENT (Biological) $312.68
- Amitiza (Drug) $303.00
- Humira (Biological) $252.40
- Entyvio (Biological) $222.26
- XIFAXANIBSD (Drug) $215.93
- VIBERZI (Drug) $200.69
- Trulance (Drug) $187.92
- IBSRELA (Drug) $172.40
- TREMFYA (Drug) $168.49
- LINZESS (Drug) $165.74
- Linzess (Drug) $161.29
- XELJANZ (Drug) $151.23
- CREON (Drug) $145.70
- REMICADE (Biological) $140.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Newark
Dr. Paul Gaglio, Md, MD
Gastroenterology — Payments: $461,099
Zamir Brelvi, M.d, M.D
Gastroenterology — Payments: $444,610
Gaurav Jain, Md, MD
Gastroenterology — Payments: $10,281
Dr. Jared Hossack, M.d, M.D
Gastroenterology — Payments: $10,266
Jorge Uribe, Md, MD
Gastroenterology — Payments: $10,111
Dr. Ghulam Mujtaba, Md, MD
Gastroenterology — Payments: $8,181